Answer
Oritavancin diphosphate is contraindicated in patients with hypersensitivity to oritavancin or any excipient in the product.
Sources for this answer
- Tenkasi 400 mg powder for concentrate for solution for infusionA. Menarini Farmaceutica Internazionale SRL · emc · SmPC §4.3 Contraindications · Version 4Document updated
Sources checked